Work

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

Year: 2020

Type: review

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/rccm.201912-2384pp

Authors: Dave Singh, Mona Bafadhel, Christopher E. Brightling, Frank C. Sciurba, Jeffrey L. Curtis, Fernando J. Martinez, Cara B. Pasquale, Debora D. Merrill, Norbert Metzdorf, Stefano Petruzzelli, Ruth Tal-Singer, Christopher Compton, Stephen Rennard, Ubaldo J. Martin

Institutions: University of Manchester, University of Oxford, University of Leicester, National Institute for Health and Care Research, NIHR Leicester Biomedical Research Centre, University of Pittsburgh, University of Michigan, VA Ann Arbor Healthcare System, Michigan Medicine, Ann Arbor VA Medical Center, Weill Cornell Medicine, COPD Foundation, Boehringer Ingelheim (Germany), Chiesi (Italy), GlaxoSmithKline (United Kingdom), AstraZeneca (United Kingdom), University of Nebraska Medical Center, AstraZeneca (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funder: U.S. Department of Veterans Affairs

Award: G2331765193

OpenAlex ID: W3010926373

FWCI: 2.111

Cites: 77

Cited by: 109

Related to: 10